Warning: The NCBI web site requires JavaScript to function. more...
BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance.
Farkas B, Boldizsar F, Tarjanyi O, Laszlo A, Lin SM, Hutas G, Tryniszewska B, Mangold A, Nagyeri G, Rosenzweig HL, Finnegan A, Mikecz K, Glant TT.
Arthritis Res Ther. 2009;11(1):R21. Epub 2009 Feb 16.
Related citations
Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease.
Glant TT, Bárdos T, Vermes C, Chandrasekaran R, Valdéz JC, Otto JM, Gerard D, Velins S, Lovász G, Zhang J, Mikecz K, Finnegan A.
Arthritis Rheum. 2001 Mar;44(3):682-92.
A longitudinal study on an autoimmune murine model of ankylosing spondylitis.
Bárdos T, Szabó Z, Czipri M, Vermes C, Tunyogi-Csapó M, Urban RM, Mikecz K, Glant TT.
Ann Rheum Dis. 2005 Jul;64(7):981-7. Epub 2005 Jan 7.
The genetic background of ankylosing spondylitis.
Végvári A, Szabó Z, Szántó S, Glant TT, Mikecz K, Szekanecz Z.
Joint Bone Spine. 2009 Dec;76(6):623-8. Epub . Review.
Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines.
Finnegan A, Mikecz K, Tao P, Glant TT.
J Immunol. 1999 Nov 15;163(10):5383-90.
Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology.
Glant TT, Mikecz K, Arzoumanian A, Poole AR.
Arthritis Rheum. 1987 Feb;30(2):201-12.
Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
Glant TT, Mikecz K.
Methods Mol Med. 2004;102:313-38.
Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F, He X, Iwakura Y, Horai R, Stuart JM.
Arthritis Rheum. 2005 Dec;52(12):3731-8.
Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.
Glant TT, Radacs M, Nagyeri G, Olasz K, Laszlo A, Boldizsar F, Hegyi A, Finnegan A, Mikecz K.
Arthritis Rheum. 2011 May;63(5):1312-21. doi: 10.1002/art.30261.
Cartilage proteoglycan-induced arthritis in BALB/c mice. Antibodies that recognize human and mouse cartilage proteoglycan and can cause depletion of cartilage proteoglycan with little or no synovitis.
Dayer E, Mathai L, Glant TT, Mikecz K, Poole AR.
Arthritis Rheum. 1990 Sep;33(9):1394-405.
Two major interacting chromosome loci control disease susceptibility in murine model of spondyloarthropathy.
Végvári A, Szabó Z, Szántó S, Nesterovitch AB, Mikecz K, Glant TT, Adarichev VA.
J Immunol. 2005 Aug 15;175(4):2475-83.
Genetic control of experimental spondylarthropathy.
Szabó Z, Szántó S, Végvári A, Szekanecz Z, Mikecz K, Glant TT.
Arthritis Rheum. 2005 Aug;52(8):2452-60.
Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Szántó S, Bárdos T, Szabó Z, David CS, Buzás EI, Mikecz K, Glant TT.
Arthritis Rheum. 2004 Jun;50(6):1984-95.
Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan.
Mikecz K, Glant TT, Poole AR.
Arthritis Rheum. 1987 Mar;30(3):306-18.
Colony variability under the spotlight in animal models of arthritis.
Robinson JH.
Arthritis Res Ther. 2009;11(2):110. Epub 2009 Apr 30.
Sex effect on clinical and immunologic quantitative trait loci in a murine model of rheumatoid arthritis.
Adarichev VA, Nesterovitch AB, Bárdos T, Biesczat D, Chandrasekaran R, Vermes C, Mikecz K, Finnegan A, Glant TT.
Arthritis Rheum. 2003 Jun;48(6):1708-20.
Proteoglycan-specific autoreactive antibodies and T-lymphocytes in experimental arthritis and human rheumatoid joint diseases.
Glant TT, Fülöp C, Mikecz K, Buzás E, Molnár G, Erhardt P.
Biochem Soc Trans. 1990 Oct;18(5):796-9. Review. No abstract available.
Disease-associated qualitative and quantitative trait loci in proteoglycan-induced arthritis and collagen-induced arthritis.
Glant TT, Adarichev VA, Nesterovitch AB, Szanto S, Oswald JP, Jacobs JJ, Firneisz G, Zhang J, Finnegan A, Mikecz K.
Am J Med Sci. 2004 Apr;327(4):188-95.
Experimental spondyloarthropathies: animal models of ankylosing spondylitis.
Adarichev VA, Glant TT.
Curr Rheumatol Rep. 2006 Aug;8(4):267-74. Review.
Immunomodulation of proteoglycan-induced progressive polyarthritis by leflunomide.
Glant TT, Mikecz K, Bartlett RR, Deák F, Thonar EJ, Williams JM, Mattar T, Kuettner KE, Schleyerbach R.
Immunopharmacology. 1992 Mar-Apr;23(2):105-16.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on